Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Carbylan Therapeutics CBYL

Healthcare Drug Manufacturers - Specialty & Generic
"Carbylan Therapeutics Inc is a clinical-stage specialty pharmaceutical company. The Company is engaged in the development and commercialization of novel and proprietary combination therapies that address unmet medical needs."
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:CBYL)

Research Reports Coverage on Generic Drugs Stocks -- SCYNEXIS, Supernus Pharma, Lipocine, and Carbylan Therapeutics

PR Newswire October 5, 2016

Carbylan Shareholder (CBYL) Alert: Shareholder Rights Law Firm Johnson & Weaver, LLP Continues its Investigation of Carbylan Therapeutics, Inc.; Encourages Investors to Contact the Firm

PR Newswire September 23, 2016

Research Report Initiation on Generic Drugs Makers Stocks -- Ironwood Pharma, The Medicines, Carbylan Therapeutics, and Pacira Pharma

PR Newswire August 24, 2016

Carbylan Therapeutics and KalVista Pharmaceuticals Conference Call to Discuss Proposed Transaction

GlobeNewswire June 22, 2016

Benzinga's M&A Chatter for Wednesday June 15, 2016

Benzinga.com  June 15, 2016

7 Biggest Mid-Day Losers For Wednesday

Benzinga.com  June 15, 2016

Mid-Day Market Update: Patriot National Climbs Following Offer from Ebix; Carbylan Therapeutics Shares Tumble

Benzinga.com  June 15, 2016

12 Stocks Moving In Wednesday's Pre-Market Session

Benzinga.com  June 15, 2016

Carbylan Therapeutics, Inc. and KalVista Pharmaceuticals Ltd. Enter into Share Purchase Agreement

GlobeNewswire June 15, 2016
View More News ››

Opinion & Analysis (NDAQ:CBYL)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:CBYL)

Webcast of Presentation of June 23/2015

http://wsw.com/webcast/jmp27/cbyl/index.aspx
dannizen - July 6, 2015
View more Bullboard ››

Bocana Resources Corp.

Bocana Resources Corp.

Bocana is a mineral exploration company focused on the acquisition, exploration and development of mineral properties in ...
View More »